Overview
Evan Siegel is a Rheumatologist in Rockville, Maryland. Dr. Siegel is rated as an Advanced provider by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Psoriatic Arthritis, Psoriasis, Postmenopausal Osteoporosis, and Osteoporosis.
His clinical research consists of co-authoring 20 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
14995 Shady Grove Rd, Suite 250, Rockville, MD 20850
Additional Areas of Focus
Dr. Siegel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Johns Hopkins Bayview Medical Center
Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Elite provider by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.
Kaitlin Quinn is a Rheumatologist in Washington, Washington, D.c.. Dr. Quinn is rated as an Elite provider by MediFind in the treatment of Temporal Arteritis. Her top areas of expertise are Takayasu Arteritis, Relapsing Polychondritis, Vasculitis, and MAGIC Syndrome.
Johns Hopkins Bayview Medical Center
Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is rated as a Distinguished provider by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- OsteoporosisDr. Siegel isDistinguished. Learn about Osteoporosis.
- Postmenopausal OsteoporosisDr. Siegel isDistinguished. Learn about Postmenopausal Osteoporosis.
- PsoriasisDr. Siegel isDistinguished. Learn about Psoriasis.
- Psoriatic ArthritisDr. Siegel isDistinguished. Learn about Psoriatic Arthritis.
- Advanced
- Ankylosing SpondylitisDr. Siegel isAdvanced. Learn about Ankylosing Spondylitis.
- Axial Spondyloarthritis (AxSpA)Dr. Siegel isAdvanced. Learn about Axial Spondyloarthritis (AxSpA).
- BursitisDr. Siegel isAdvanced. Learn about Bursitis.
- Calcium Pyrophosphate ArthritisDr. Siegel isAdvanced. Learn about Calcium Pyrophosphate Arthritis.
- Giant Cell Arteritis (GCA)Dr. Siegel isAdvanced. Learn about Giant Cell Arteritis (GCA).
- Juvenile Temporal ArteritisDr. Siegel isAdvanced. Learn about Juvenile Temporal Arteritis.
- Experienced
- Adult Still's DiseaseDr. Siegel isExperienced. Learn about Adult Still's Disease.
- ArthritisDr. Siegel isExperienced. Learn about Arthritis.
- Behcet DiseaseDr. Siegel isExperienced. Learn about Behcet Disease.
- DermatomyositisDr. Siegel isExperienced. Learn about Dermatomyositis.
- Diffuse Idiopathic Skeletal Hyperostosis
- Ehlers-Danlos Syndrome (EDS)Dr. Siegel isExperienced. Learn about Ehlers-Danlos Syndrome (EDS).